The Latest Analyst Ratings For Ovid Therapeutics
The Latest Analyst Ratings For Ovid Therapeutics
Ovid Therapeutics的最新分析师评级
Ratings for Ovid Therapeutics (NASDAQ:OVID) were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在过去三个月中，10位分析师提供了Ovid Therapeutics（纳斯达克股票代码：OVID）的评级，显示了看涨和看跌的观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Analysts have recently evaluated Ovid Therapeutics and provided 12-month price targets. The average target is $4.87, accompanied by a high estimate of $9.00 and a low estimate of $1.20. This current average represents a 24.38% decrease from the previous average price target of $6.44.
分析师最近对Ovid Therapeutics进行了评估，并提供了12个月的目标股价。平均目标为4.87美元，最高估计值为9.00美元，低估值为1.20美元。目前的平均价格比之前的平均目标价6.44美元下降了24.38％。
Exploring Analyst Ratings: An In-Depth Overview
探索分析师评级：深入概述
The perception of Ovid Therapeutics by financial experts is...
通过分析师最近的行...
登录免费看全文
登录/注册